UFP INDUSTRIES INC

For the period ended Sep 26, 2026. Filed Nov 4, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 26, 2026 · Filed Nov 4, 2026

UFPI$82.66+3.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

PART I.		FINANCIAL INFORMATION.	Page No.

	Item 1.	Financial Statements	3

		Condensed Consolidated Balance Sheets at September 26, 2026, December 27, 2025 and September 27, 2025	3

		Condensed Consolidated Statements of Earnings and Comprehensive Income for the Three and Nine Months Ended September 26, 2026 and September 27, 2025	4

		Condensed Consolidated Statements of Shareholders’ Equity for the Three and Nine Months Ended September 26, 2026 and September 27, 2025	5

		Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 26, 2026 and September 27, 2025	7

		Notes to Unaudited Condensed Consolidated Financial Statements	8

	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21

	Item 3.	Quantitative and Qualitative Disclosures about Market Risk	40

	Item 4.	Controls and Procedures	40

PART II.		OTHER INFORMATION

	Item 1.	Legal Proceedings – NONE

	Item 1A.	Risk Factors	41

	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	41

	Item 3.	Defaults upon Senior Securities – NONE

	Item 4.	Mine Safety Disclosures – NONE

	Item 5.	Other Information	42

	Item 6.	Exhibits	43

CONDENSED CONSOLIDATED BALANCE SHEETS


(in thousands of United States dollars, except share data) · · September 26, · · December 27, · · September 27, ·
· · 2026 · · 2025 · · 2025 ·
Assets
Current assets
Cash and cash equivalents	$677,446	$914,199	$1,008,632
Restricted cash	1,093	10,872	3,062
Investments	47,526	34,374	33,926
Accounts receivable, net	684,638	475,959	607,537
Inventories:
Raw materials	389,597	380,206	354,021
Finished goods	357,932	341,814	313,397
Total inventories	747,529	722,020	667,418
Income taxes receivable	17,010	38,373	2,571
Assets held for sale	488	6,340	7,230
Other current assets	81,431	66,515	56,708
Total current assets	2,257,161	2,268,652	2,387,084
Deferred income taxes	10,097	8,025	5,231
Restricted investments	51,796	50,540	48,488
Right of use assets	167,367	115,790	123,369
Other assets	99,545	102,433	106,708
Goodwill	345,632	343,921	342,145
Indefinite-lived intangible assets	7,359	7,336	7,324
Other intangible assets, net	124,055	133,616	139,305
Property, plant and equipment:
Property, plant and equipment	2,093,944	1,936,470	1,900,849
Less accumulated depreciation and amortization	(1,022,990)	(943,890)	(924,952)
Property, plant and equipment, net	1,070,954	992,580	975,897
Total assets	$4,133,966	$4,022,893	$4,135,551
Liabilities, temporary equity and shareholders’ equity
Current liabilities
Accounts payable	$279,768	$205,932	$231,905
Accrued compensation and benefits	189,204	188,354	183,619
Other accrued liabilities	82,986	71,039	82,537
Current portion of lease liability	26,964	27,997	28,767
Current portion of long-term debt	5,247	899	5,386
Total current liabilities	584,169	494,221	532,214
Long-term debt and finance lease obligations	229,114	228,859	229,007
Lease liability	150,111	99,085	106,100
Deferred income taxes	82,944	83,205	30,270
Other liabilities	31,067	28,816	29,687
Total liabilities	1,077,405	934,186	927,278
Temporary Equity
Redeemable noncontrolling interest	476	4,463	5,018
Shareholders’ equity
Controlling interest shareholders’ equity:
Preferred stock, no par value; shares authorized 1,000,000; issued and outstanding, none	—	—	—
Common stock, $1 par value; shares authorized 240,000,000; issued and outstanding, 54,595,341, 56,591,900 and 58,257,224	54,595	56,592	58,257
Additional paid-in capital	476,506	444,828	434,441
Retained earnings	2,505,340	2,559,375	2,689,507
Accumulated other comprehensive (loss) income	(687)	1,564	(1,760)
Total controlling interest shareholders’ equity	3,035,754	3,062,359	3,180,445
Noncontrolling interest	20,331	21,885	22,810
Total shareholders’ equity	3,056,085	3,084,244	3,203,255
Total liabilities, temporary equity and shareholders’ equity	$4,133,966	$4,022,893	$4,135,551

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS

AND COMPREHENSIVE INCOME


(in thousands of United States dollars, except per share data) · · Three Months Ended · · Nine Months Ended
· · September 26, · · September 27, · · September 26, · · September 27,
· · 2026 · · 2025 · · 2026 · · 2025
Net sales	$1,732,836	$1,559,627	$5,077,040	$4,990,520
Cost of sales	1,487,915	1,296,946	4,305,995	4,146,909
Gross profit	244,921	262,681	771,045	843,611

Operating expenses
Selling, general and administrative expenses	178,091	170,030	536,694	531,279
Net (gain) loss on disposition and impairments of assets	(3,184)	2,458	(4,534)	6,212
Other (income) losses, net	(142)	722	1,232	1,306
Total operating expenses	174,765	173,210	533,392	538,797

Earnings from operations	70,156	89,471	237,653	304,814

Interest and other
Interest expense	2,708	2,757	7,339	8,142
Interest and investment income	(7,337)	(12,142)	(23,298)	(34,016)
Equity in earnings of investee	(2,087)	(278)	(3,066)	(1,072)
Total interest and other	(6,716)	(9,663)	(19,025)	(26,946)

Earnings before income taxes	76,872	99,134	256,678	331,760
Income taxes	18,239	23,592	63,777	75,924
Net earnings	58,633	75,542	192,901	255,836
Less net earnings attributable to noncontrolling interest	(668)	(196)	(1,290)	(1,003)
Net earnings attributable to controlling interest	$57,965	$75,346	$191,611	$254,833

Earnings per share - basic	$1.05	$1.29	$3.43	$4.29
Earnings per share - diluted	$1.05	$1.29	$3.43	$4.28

Other comprehensive income:
Net earnings	58,633	75,542	$192,901	$255,836
Other comprehensive (loss) income	(910)	507	(2,062)	15,426
Comprehensive income	57,723	76,049	190,839	271,262
Less comprehensive income attributable to noncontrolling interest	(396)	(487)	(1,479)	(2,878)
Comprehensive income attributable to controlling interest	$57,327	$75,562	$189,360	$268,384

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY


(in thousands of United States dollars, · · Controlling Interest Shareholders’ Equity · · ·
except share and per share data) · · · · · Additional · · · · · Accumulated Other · · · · · · · · ·
· · Common · · Paid-In · · Retained · · Comprehensive · · Noncontrolling · · · · · Temporary
· Stock · · Capital · · Earnings · · Loss · · Interest (NCI) · · Total · Equity
Balance on December 27, 2025	$56,592	$444,828	$2,559,375	$1,564	$21,885	$3,084,244	$4,463
Net earnings			50,774		305	51,079	18
Foreign currency translation adjustment				(1,220)	(6)	(1,226)	(59)
Unrealized gain on debt securities				382		382
Distributions to NCI					(1,082)	(1,082)
Purchase of remaining NCI of subsidiary						—	(3,937)
Other		(167)				(167)
Cash dividends - $0.36 per share - quarterly			(20,456)			(20,456)
Issuance of 7,575 shares under employee stock purchase plan	8	570				578
Issuance of 144,425 shares under stock grant programs	144	1,896	38			2,078
Issuance of 70,871 shares under deferred compensation plans	71	(71)				—
Repurchase of 334,541 shares	(335)	(1,193)	(28,501)			(30,029)
Expense associated with share-based compensation arrangements		8,409				8,409
Accrued expense under deferred compensation plans		6,881				6,881
Balance on March 28, 2026	$56,480	$461,153	$2,561,230	$726	$21,102	$3,100,691	$485
Net earnings			82,872		299	83,171
Foreign currency translation adjustment				(162)	526	364
Unrealized loss on debt securities				(613)		(613)
Other		(1,169)				(1,169)
Cash dividends - $0.36 per share - quarterly			(19,934)			(19,934)
Issuance of 8,452 shares under employee stock purchase plan	8	655				663
Net forfeitures of 2,267 shares under stock grant programs	(2)	47	2			47
Issuance of 10,305 shares under deferred compensation plans	10	(10)				—
Repurchase of 1,335,229 shares	(1,335)	(184)	(110,300)			(111,819)
Expense associated with share-based compensation arrangements		6,948				6,948
Accrued expense under deferred compensation plans		1,094				1,094
Balance on June 27, 2026	$55,161	$468,534	$2,513,870	$(49)	$21,927	$3,059,443	$485
Net earnings			57,965		668	58,633	—
Foreign currency translation adjustment				(61)	(263)	(324)	(9)
Unrealized loss on debt securities				(577)		(577)
Other		(425)				(425)
Distributions to NCI					(2,001)	(2,001)
Cash dividends - $0.36 per share - quarterly			(19,809)			(19,809)
Issuance of 8,621 shares under employee stock purchase plan	9	574				583
Net forfeitures of 4,596 shares under stock grant programs	(5)	57	3			55
Issuance of 10,994 shares under deferred compensation plans	11	(11)				—
Repurchase of 581,169 shares	(581)	(66)	(46,689)			(47,336)
Expense associated with share-based compensation arrangements		6,728				6,728
Accrued expense under deferred compensation plans		1,115				1,115
Balance on September 26, 2026	$54,595	$476,506	$2,505,340	$(687)	$20,331	$3,056,085	$476

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY, CONTINUED


(in thousands of United States dollars, · · Controlling Interest Shareholders’ Equity · · ·
except share and per share data) · · · · · Additional · · · · · Accumulated Other · · · · · · · · ·
· · Common · · Paid-In · · Retained · · Comprehensive · · Noncontrolling · · · · · Temporary
· · Stock · · Capital · · Earnings · · Earnings (Loss) · · Interest (NCI) · · Total · · Equity
Balance on December 28, 2024	$60,724	$403,379	$2,775,280	$(15,311)	$20,553	$3,244,625	$5,366
Net earnings (loss)			78,753		853	79,606	(183)
Foreign currency translation adjustment				2,744	(31)	2,713	(2)
Unrealized gain on debt securities				470		470
Other		(355)				(355)	99
Cash dividends - $0.35 per share - quarterly			(21,322)			(21,322)
Issuance of 7,197 shares under employee stock purchase plan	7	643				650
Issuance of 232,101 shares under stock grant programs	232	3,055	101			3,388
Issuance of 80,341 shares under deferred compensation plans	81	(81)				—
Repurchase of 649,060 shares	(649)	(9,460)	(59,991)			(70,100)
Expense associated with share-based compensation arrangements		11,493				11,493
Accrued expense under deferred compensation plans		7,888				7,888
Balance on March 29, 2025	$60,395	$416,562	$2,772,821	$(12,097)	$21,375	$3,259,056	$5,280
Net earnings (loss)			100,734		376	101,110	(239)
Foreign currency translation adjustment				10,239	1,615	11,854	2
Unrealized loss on debt securities				(118)		(118)
Other		(1,818)				(1,818)	210
Distributions to NCI					(285)	(285)
Cash dividends - $0.35 per share - quarterly			(20,656)			(20,656)
Issuance of 7,593 shares under employee stock purchase plan	8	636				644
Issuance of 26,949 shares under stock grant programs	27	17	1			45
Issuance of 10,998 shares under deferred compensation plans	10	(10)				—
Repurchase of 1,874,279 shares	(1,874)	(13)	(189,506)			(191,393)
Expense associated with share-based compensation arrangements		8,755				8,755
Accrued expense under deferred compensation plans		1,269				1,269
Balance on June 28, 2025	$58,566	$425,398	$2,663,394	$(1,976)	$23,081	$3,168,463	$5,253
Net earnings (loss)			75,346		253	75,599	(55)
Foreign currency translation adjustment				(354)	471	117	(180)
Unrealized gain on debt securities				570		570
Other		(177)				(177)
Distributions to NCI					(995)	(995)
Cash dividends - $0.35 per share - quarterly			(20,512)			(20,512)
Issuance of 7,299 shares under employee stock purchase plan	7	565				572
Net forfeitures of 30,601 shares under stock grant programs	(30)	37	37			44
Issuance of 10,940 shares under deferred compensation plans	11	(11)				—
Repurchase of 296,562 shares	(297)	(22)	(28,758)			(29,077)
Expense associated with share-based compensation arrangements		7,497				7,497
Accrued expense under deferred compensation plans		1,154				1,154
Balance on September 27, 2025	$58,257	$434,441	$2,689,507	$(1,760)	$22,810	$3,203,255	$5,018

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.

About this filing

Table of Contents